Bill Text: LA HB403 | 2023 | Regular Session | Chaptered

Bill Title: Authorizes substitution of certain biosimilar biological products relative to step therapy or fail first protocols

Sponsorship: Partisan Bill (Democrat 1)

Status: (Passed) 2023-06-06 - Effective date: 08/01/2023. [HB403 Detail]

Download: Louisiana-2023-HB403-Chaptered.pdf
It appears your computer is unable to display this document, however you can download the file from the links above.

LegiScan Search

View Top 50 Searches

Select area of search.
Find an exact bill number.
Search bill text and data. [help]
Reset

LegiScan Trends

View Top 50 National

CA AB2691 Elections: elective office: felony conviction.
CA SB109 Budget Act of 2026.
CA AB1237 Swimming pool safety: building codes: condominium and hotel rooms.
US HB9358 Improving the Lives of the American People Act Restore Trust in Government...
CA SB1190 Child welfare: transport escort services.
MI SB1078 Public utilities: other; certain money spent by electric or natural gas...
NY S05189 Establishes a comprehensive electric vehicle fast charging station implementation...
PA HB2426 Amending the act of March 29, 1803 (P.L.542, No.156), entitled "An act...
IL SB3066 CONSUMERS-SERVICE APPOINTMENTS
CO SB015 Commercial Sexual Activity with a Child Offenses
feedback